Clinical Trial Update: Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA [NA]

View source ↗

Summary

A completed clinical trial evaluating the Jetstream device for treating occlusive atherosclerotic lesions in the superficial femoral and/or popliteal arteries, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Peripheral Artery Disease

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atherosclerosis | NA | Status: COMPLETED | Results posted: 2024-09-19